Mekha A. Thomas

Mekha A. Thomas

Auto-generated profile, based on publicly available information

Mekha A. Thomas

Johns Hopkins University School of Medicine Baltimore Maryland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
JCJonathan D. Crawford
Jonathan D. Crawford
HWHong Wang
Hong Wang
DTDaniela Trejo-Zambrano
Daniela Trejo-Zambrano
IMIvana Munitic
Ivana Munitic
CTC. Conover Talbot
C. Conover Talbot
EDErika Darrah
Erika Darrah
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a dramatic sex bias, affecting 9 times more women than men. Activation of Toll-like receptor 7 (TLR7) by self-RNA is a central pathogenic process leading to aberrant production of type I interferon (IFN) in SLE, but the specific RNA molecules that serve as TLR7 ligands have not been defined. By leveraging gene expression data and the known sequence specificity of TLR7, we identified the female-specific X-inactive specific transcript (XIST) long noncoding RNA as a uniquely rich source of TLR7 ligands in SLE. XIST RNA stimulated IFN-α production by plasmacytoid DCs in a TLR7-dependent manner, and deletion of XIST diminished the ability of whole cellular RNA to activate TLR7. XIST levels were elevated in blood leukocytes from women with SLE compared with controls, correlated positively with disease activity and the IFN signature, and were enriched in extracellular vesicles released from dying cells in vitro. Importantly, XIST was not IFN inducible, suggesting that XIST is a driver, rather than a consequence, of IFN in SLE. Overall, our work elucidated a role for XIST RNA as a female sex–specific danger signal underlying the sex bias in SLE.

24 February 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAshley M. Curran
Ashley M. Curran
AGAlexander A. Girgis
Alexander A. Girgis
YJYura Jang
Yura Jang
JCJonathan D. Crawford
Jonathan D. Crawford
MTMekha A. Thomas
Mekha A. Thomas
EDErika Darrah
Erika Darrah
Cryptic peptides, hidden from the immune system under physiologic conditions, are revealed by changes to MHC class II processing and hypothesized to drive the loss of immune tolerance to self-antigens in autoimmunity. Rheumatoid arthritis (RA) is an autoimmune disease characterized by immune responses to citrullinated self-antigens, in which arginine residues are converted to citrullines. Here, we investigate the hypothesis that citrullination exposes cryptic peptides by modifying protein structure and proteolytic cleavage. We show that citrullination alters processing and presentation of autoantigens, resulting in the generation of a unique citrullination-dependent repertoire composed primarily of native sequences. This repertoire stimulates T cells from RA patients with anti-citrullinated protein antibodies more robustly than controls. The generation of this unique repertoire is achieved through altered protease cleavage and protein destabilization, rather than direct presentation of citrulline-containing epitopes, suggesting a novel paradigm for the role of protein citrullination in the breach of immune tolerance in RA.

13 January 2020 in Immunological Reviews
Verified
Journal Article
Closed access
LCLaura C. Cappelli
Laura C. Cappelli
MTMekha A. Thomas
Mekha A. Thomas
CBClifton O. Bingham
Clifton O. Bingham
ASAmi A. Shah
Ami A. Shah
EDErika Darrah
Erika Darrah

28 August 2022 in Psychiatry Research
Verified
Journal Article
Closed access
WEWilliam W. Eaton
William W. Eaton
KRKatrina M. Rodriguez
Katrina M. Rodriguez
MTMekha A. Thomas
Mekha A. Thomas
JJJeanette Johnson
Jeanette Johnson
MTMonica V. Talor
Monica V. Talor
EDErika Darrah
Erika Darrah

2 October 2023 in Philosophical Transactions of the Royal Society B: Biological Sciences
Verified
Journal Article
Open access
MTMekha A. Thomas
Mekha A. Thomas
SKSeok-Young Kim
Seok-Young Kim
ACAshley M. Curran
Ashley M. Curran
BSBarbara Smith
Barbara Smith
BABrendan Antiochos
Brendan Antiochos
EDErika Darrah
Erika Darrah
Peptidylarginine deiminase IV (PAD4) post-translationally converts arginine residues in proteins to citrullines and is implicated in playing a central role in the pathogenesis of several diseases. Although PAD4 was historically thought to be a nuclear enzyme, recent evidence has revealed a more complex localization of PAD4 with evidence of additional cytosolic and cell surface localization and activity. However, the mechanisms by which PAD4, which lacks conventional secretory signal sequences, traffics to extranuclear localizations are unknown. In this study, we show that PAD4 was enriched in the organelle fraction of monocytes with evidence of citrullination of organelle proteins. We also demonstrated that PAD4 can bind to several cytosolic, nuclear and organelle proteins that may serve as binding partners for PAD4 to traffic intracellularly. Additionally, cell surface expression of PAD4 increased with monocyte differentiation into monocyte-derived dendritic cells and co-localized with several endocytic/autophagic and conventional secretory pathway markers, implicating the use of these pathways by PAD4 to traffic within the cell. Our results suggest that PAD4 is expressed in multiple subcellular localizations and may play previously unappreciated roles in physiological and pathological conditions. This article is part of the Theo Murphy meeting issue ‘The virtues and vices of protein citrullination’.

27 May 2025 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
TWTaejoon Won
Taejoon Won
PNPooja Naik
Pooja Naik
MWMegan K. Wood
Megan K. Wood
HWHong Wang
Hong Wang
MTMonica V. Talor
Monica V. Talor
EDErika Darrah
Erika Darrah